Showing posts with label Chemotherapy. Show all posts
Showing posts with label Chemotherapy. Show all posts

Chabner: Cancer Chemotherapy and Biotherapy: Principles and Practice 5th Edition

Section 1: BASIC PRINCIPLES OF CANCER TREATMENT
  • 1: Clinical Strategies for Cancer Treatment: The Role of Drugs
  • 2: Target Identification and Drug Discovery
  • 3: Clinical Drug Development and Approval for Marketing
  • 4: Principles of Pharmacokinetics
  • 5: Special Aspects of Brain Tumor Chemotherapy
  • 6: Pharmacogenetics
  • 7: Barriers to Drug Delivery
Section 2: CYTOTOXIC AGENTS
  • 8: Antifolates
  • 9: Fluoro-pyrimidines
  • 10: Cytidine Analogues
  • 11: Purine Analogues
  • 12: Hydroxyurea
  • 13: Antimitotic Drugs
  • 14: Alkylating Agents (Including Methylating Agents)
  • 15: Platinum Analogues
  • 16: Antitumor Antibiotics (Including Bleomycin)
  • 17: Topoisomerase I Inhibitors
  • 18: Topoisomerase II Inhibitors: Anthracyclines
  • 19: Topoisomerase II Inhibitors: Etoposide, Teniposide
  • 20: L-Asparaginase
Section 3: MOLECULARLY TARGETED THERAPIES
  • 21: Proteosome Inhibitors
  • 22: HDAC Inhibitors
  • 23: Differentiating Agents (Retinoids)
  • 24: Arsenic Trioxide
  • 25: Monoclonal Antibodies: Discovery & Development
  • 26: Anti-angiogenic Agents (Including MonAB)
  • 27: Anti-EGFR Therapies (Including MonAB)
  • 28: Anti-her 2 Therapies
  • 29: Intracellular Signal Inhibitors (bcr-abl)
  • 30: Signal Transduction Inhibitors in Development
  • 31: Inhibitors of the PI3k Pathway & Mitotic Kinase
Section 4: IMMUNOLOGIC AGENTS
  • 32: Interferon and Cytokines
  • 33: Vaccines
  • 34: Adoptive Cellular Therapies
  • 35: Immuno-modulatory Drugs (IMIDS, Anti-CTLA4)
Section 5: HORMONAL THERAPY
  • 36: Hormonal Therapy of Breast Cancer
  • 37: GNRH Agonists and Anti-Androgens
Section 6: SUPPORTIVE CARE
  • 38: Pain Management in Cancer Patients
  • 39: Colony Stimulating Factors
  • 40: Anti-nausea Medications
  • 41: Bone Loss Modulators
  • 42: Intravenous Access and Catheter Management
Section 7: SURVIVORSHIP
  • 43: Monitoring for Late Side Effects of Chemotherapy 


Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents.

Organized by drug class, the book provides the latest information on all drugs and biological agents—their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance.

Chapters emphasize pharmacology and mechanisms of action at the molecular and cellular levels, followed by clinical activity and toxicity, both acute and delayed. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations.

This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised.

A companion website includes the fully searchable text and an image bank.


Book Details

  • Hardcover: 848 pages
  • Publisher: Lippincott Williams & Wilkins; Fifth edition (December 31, 2010)
  • Language: English
  • ISBN-10: 1605474312
  • ISBN-13: 978-1605474311
  • Product Dimensions: 11.1 x 8.7 x 1.5 inches
List Price: $225.00 
 

Gullatte: Clinical Guide to Antineoplastic Therapy 2nd edition: A Chemotherapy Handbook

Newly updated and expanded to reflect new research and clinical advances in oncology, this resource provides you with detailed information on all facets of chemotherapy administration. New to this edition are chapters on targeted therapy, chemotherapy regimens, complementary and alternative therapy, botanicals, and reimbursement issues. Also included are more than 100 detailed drug monographs on current chemotherapeutic, biotherapeutic, and hormonal agents based on current guidelines from the manufacturers and the U.S. Food and Drug Administration. Whether in the classroom or clinical setting, this new edition is a must-have!

About the Author
Mary Magee Gullatte comes with more than 29 years of oncology nursing experience and is currently the associate chief nursing officer of the Oncology Ambulatory Treatment Centers for the Emory Crawford Long Hospital of Emory Healthcare in midtown Atlanta. She is an accomplished author and is editor of Nursing Management: Principles and Practice, a 2005 American Journal of Nursing Book of the Year winner in the leadership and management category.

Contents 
Chapter 1.Cellular Mechanisms of Chemotherapy1

Overview1

Normal and Malignant Cell Growth1

Immunology: Host Defense3

Histology of Cancer6

Cancer Physiology7

Goals of Chemotherapy7

Cell Phase Specificity8

Tumor Response Criteria9

Factors Affecting Chemotherapy Response9
Chapter 2.Pharmacologic Principles of Chemotherapy13

Overview13

Treatment Goals21

Cell-Cycle Response of Chemotherapy21

Alkylating Agents22

Toxicity of Alkylating Agents23

Antimetabolities23

Antitumor Antibiotics25

Biologic Agents25

Hormones26

Plant Alkaloids27
Chapter 3.Principles and Standards of Chemotherapy Administration31

Introduction31

Preparation and Administration34

Chemotherapy Protective Agents35

Routes of Chemotherapy Administration35

Safe Handling and Disposal40

Latex Sensitivity41

Patient and Significant Other Education and Support42
Chapter 4.Vascular Access Devices47

Introduction47

Brief History of Vascular Access Devices47

Central Venous Catheters48

Implanted Ports and Reservoirs52

Peripherally Inserted Central Catheters54

Alternative Administration Devices55

Ambulatory Infusion Pumps64

Pertinent Documentation for All Vascular Access Devices65

Patient/Family Education Regarding Vascular Access Devices67

Liability Issues and the Role of the Oncology Nurse67

Research Questions67
Chapter 5.Antineoplastic Agents71

History71

Principles of Chemotherapy71

Classification71

Chemotherapy (A-Z)72

Abbreviations used in Chapter 574

Chemotherapeutic Agents75

Hormonal Therapies227

Biotherapeutics255
Chapter 6.Legal Issues in Chemotherapy Administration281

Source of Laws281

Nursing Liability283

Liability Issues for Nurses285

Clinical Trials288

Liability Regarding Chemotherapy Administration289
Chapter 7.Symptom Management297

Nausea and Vomiting297

Mucositis304

Taste Changes307

Fatigue307

Pain311

Bone Marrow Suppression313
Chapter 8.Clinical Trials321

Institutional Review Boards322

Drug Development Process322

Informed Consent325

Educational Resources326
Chapter 9.Psychosocial Support of the Patient Receiving Chemotherapy329

Social Support Theory329

Support of Patient and Caregivers331

Systems Theory for Support Group Development334

Support Groups335

Cancer Survivorship Issues337
Chapter 10.Public and Professional Cancer Resources351

Public Resources351

Professional Resources and Organizations355

Funding Sources358

Patient and Professional Information Resources on the World Wide Web359

Cancer Statistics361

Index363

Product Details

  • Paperback: 688 pages
  • Publisher: Oncology Nursing Society; 2nd edition (July 2, 2007)
  • Language: English
  • ISBN-10: 1890504688
  • ISBN-13: 978-1890504687
  • Product Dimensions: 9.1 x 5.9 x 1.7 inches 
List Price: $108.00

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice 3rd Edition

Order your copy of the third edition of the best-selling resource used by more than 72,000 healthcare professional. Edited by Martha Polovich, Julie M. Whitford, and MiKaela Olsen, this new edition has been revised and updated to reflect the current procedures and practices in your specialty.

Featured are sections detailing principles of :
  • antineoplastic therapy, 
  • cancer therapy goals and response, 
  • fundamentals of administration, 
  • pretreatment, treatment and post-treatment care, 
  • side effects of cancer therapy, 
  • immediate complications of cytotoxic therapy, 
  • and more. 


Also included are : 
  • treatment schedules, including dose category and determination, as well as nursing and chemotherapy flow charts, 
  • information on safe management of chemotherapy in the home, 
  • clinical practicum and evaluations, 
  • and much, much more.

Product Details

  • Spiral-bound: 376 pages
  • Publisher: Oncology Nursing Society; 3 Spi edition (April 2009)
  • Language: English
  • ISBN-10: 1890504815
  • ISBN-13: 978-1890504816
  • Product Dimensions: 11.2 x 9.5 x 1.2 inches 
  • Editor: Martha Polovich, Julie M. Whitford, MiKaela Olsen 
 List Price: $80.00

Handbook of Brain Tumor Chemotherapy

Handbook of Brain Tumor Chemotherapy by Herbert B. Newton reviews the state-of-the-art of chemotherapy development and clinical treatment of patients with this devastating disease. Handbook of Brain Tumor Chemotherapy offers a unique cutting-edge compendium of basic science and clinical information on the subject of brain tumor chemotherapy, reviewing what has been accomplished thus far and how the field will continue to evolve with the development of more specific and efficacious chemotherapeutic agents. This book represents the most complete single-volume resource available for information on the subject of brain tumor chemotherapy.

Book features:
  • Provides the most up to date information regarding conventional forms of cytotoxic chemotherapy, as well as the basic science and clinical application of molecular therapeutics, for the treatment of brain tumors.
  • Broadly appeals to anyone interested in the field of Neuro-Oncology and in the treatment of patients with brain tumors.
  • Useful to clinicians interested in a thorough overview of the use of chemotherapy in patients with a broad range of brain tumors as well as serving as a source of background information to basic scientists and pharmaceutical researchers with an interest in the molecular therapeutics of brain tumors.
Book Details
  • Hardcover: 586 pages
  • Publisher: Academic Press; 1 edition (December 13, 2005)
  • Language: English
  • ISBN-10: 0120884100
  • ISBN-13: 9780120884100
  • Product Dimensions: 11 x 8.3 x 1.1 inches
  • List Price: $180.00
  • Price: $152.50
  • You Save: $27.50 (15%)
Buy Now

Physician's Cancer Chemotherapy Drug Manual 2008 (Jones and Bartlett Series in Oncology)

Physician's Cancer Chemotherapy Drug Manual 2008 (Jones and Bartlett Series in Oncology) by Edward, M.D. Chu and Vincent T., Jr., M.D. DeVita is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalogue of over 100 drugs-both on- and off-label-commonly used in cancer treatment. A section on Common Chemotherapy Regimens provides a quick reference to management of specific cancers, arranged alphabetically.

Book Details Physician's Cancer Chemotherapy Drug Manual 2008
  • Spiral-bound: 552 pages
  • Publisher: Jones and Bartlett Publishers; 1 edition (December 28, 2007)
  • Language: English
  • ISBN-10: 0763755621
  • ISBN-13: 9780763755621
  • Product Dimensions: 8.3 x 6.7 x 1.3 inches
  • List Price: $89.95
  • Price: $74.66
  • You Save: $15.29 (17%)
Buy Button

Latest Edition of this book :
Physician's Cancer Chemotherapy Drug Manual 2011
Completely revised and updated for 2011, the Physicians Cancer Chemotherapy Drug Manual 2011 is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens both on- and off-label for the treatment of all the major cancers. Special Features Include: Revised to reflect rapid advances in the field, incorporating treatment strategie and new drugs like Cabazitaxel, Ofatumumab, Pazopanib, and Pralatrexate. A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens. Diagrams of drug structures and pathways for each agent. Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages. Covers toxicity and drug drug interactions. A section on chemotherapy regimens for all major cancers. Provides an overview of the basic principles of cancer drug therapy. Contains an easy to load and use CD-ROM version.

Product Details

  • Spiral-bound: 600 pages
  • Publisher: Jones & Bartlett Learning; 11 edition (December 16, 2010)
  • Language: English
  • ISBN-10: 1449601979
  • ISBN-13: 978-1449601973
  • Product Dimensions: 8.4 x 5.4 x 1.3 inches 
  • List Price: $89.95

The Chemotherapy Source Book 4th Edition

The Chemotherapy Source Book 4th Edition by Michael C. Perry pulls together all the current information on the chemotherapeutic management of cancer patients, including choice of chemotherapeutic agents, use of combinations, and toxicity of individual drugs. Organized by disease site, the book brings together pharmacologic and patient management information in one source that clinicians can consult for any question encountered in the delivery of chemotherapy. This updated Fourth Edition includes new drugs as well as new indications for older drugs. Content has been streamlined to provide essential information more quickly for the busy practitioner. Plus, this edition is softcover for greater portability and convenience.

Book features:
  • Provides fast access to treatment recommendations for solid tumors and hematologic malignancies.
  • Presents the latest facts about chemotherapy programs and dose modifications.
  • outlines groundbreaking drug combinations and regimens, along with new findings about side effects and scheduling.
  • Features concise yet complete coverage of essential drug information for the clinician.
  • Organizes information by disease site, a format that is helpful for both the trainee and the practitioner.
New in this edition:
  • Completely updated pharmacologic information throughout, featuring detailed coverage of the most current drugs, plus new indications for existing ones.
  • Streamlined content ant structure to provide essential information more quickly for the busy practitioner.
  • A soft-cover format for greater portability and convenience.
Book Details The Chemotherapy Source Book
  • Paperback: 800 pages
  • Publisher: Lippincott Williams & Wilkins; 4 edition (October 1, 2007)
  • Language: English
  • ISBN-10: 0781773288
  • ISBN-13: 9780781773287
  • Product Dimensions: 10.9 x 8.4 x 1.3 inches
  • List Price: $99.00
  • Price: $88.10
  • You Save: $10.90 (11%)
Buy Button

Handbook of Cancer Chemotherapy 7th edition

Handbook of Cancer Chemotherapy 7th edition by Roland T. Skeel is excellent for any busy chemotherapy infusion department's orientation program or as part of it's reference library. This pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.

Book Info
Univ. of Ohio, Toledo. Pocket-sized outline features sound decision-making tools including, site-specific information, comprehensive summary profiles, a focus on new therapeutic advances, and a detailed review of palliative and supportive care. Previous edition: c1999. Softcover. DNLM: Neoplasms--drug therapy--Handbooks.

Book Details Handbook of Cancer Chemotherapy
  • Paperback: 817 pages
  • Publisher: Lippincott Williams & Wilkins; 7 edition (May 1, 2007)
  • Language: English
  • ISBN-10: 0781765315
  • ISBN-13: 9780781765312
  • Product Dimensions: 7.8 x 4.4 x 1 inches
  • List Price: $54.95
  • Price: $49.46
  • You Save: $5.49 (10%)
Buy Button

Pocket Guide to Chemotherapy Protocols 4th Edition

Pocket Guide to Chemotherapy Protocols 4th Edition by Edward Chu is an indispensable quick reference for physicians, nurses, and other healthcare providers treating cancer patients! The updated Fourth Edition of the best-selling Pocket Guide to Chemotherapy Protocols is spiral bound and arranged alphabetically by cancer type for easy access, and contains combination as well as selected single-agent regimens for solid tumors and hematologic malignancies. In each case, the regimens selected are based on the published literature and are used in clinical practice in the medical oncology community. Pocket Guide to Chemotherapy Protocols, Fourth Edition, continues the success of previous editions by offering cancer care professionals complete, authoritative information in a convenient format.

Book Details Pocket Guide to Chemotherapy Protocols
  • Spiral-bound: 180 pages
  • Publisher: Jones and Bartlett Publishers, Inc.; 4 edition (November 2, 2007)
  • Language: English
  • ISBN-10: 0763753726
  • ISBN-13: 9780763753726
  • Product Dimensions: 5.6 x 3.4 x 0.7 inches
  • List Price: $39.95
  • Price: $26.37
  • You Save: $13.58 (34%)
Buy Button

Moss' Questioning Chemotherapy

Questioning Chemotherapy by Ralph W. Moss is a book that every person faced with cancer must read before submitting to toxic chemicals which may very well destroy the body's immune system. Unlike many alternative health authors who base their conclusions on anecdotal evidence, Moss uses the medical establishment's own research to prove that in almost all instances chemotherapy is NOT a viable approach to improving cancer survival rates.
It is comprehensive and detailed about every type of chemotherapy and every type of cancer. Side effects are horrific and natural substances which offset them are actually discouraged. Virtually nothing has changed since this book was published in 1995 except some of the drug names.
Moss also makes the important point that current cancer research has never bothered to examine the mental anguish, physical suffering, and poor quality of life endured by almost everyone whose doctors talk or scare them into undergoing chemotherapy.
Learning about the economics behind chemotherapy drives the final nail into the coffin of a "therpy" that educated people in the future will consider outrageous and reflective of the current dark ages of so-called modern medicine.
Don't be fooled by terms like "response rate" or "5-year survival." For metastatic cancer (the only kind that kills), the success rate of chemotherapy (defined as long-term remission) is 3%.
Get Dr. Moss' book and dramatically improve your chances of recovery with the knowledge he gives you here. This is a must read book for anyone who wants to know the truth behind chemotherapy or anyone whose doctor wants to inject toxic chemicals into their bloodstream.

From the Author
Hi! I'm Ralph Moss, author of Questioning Chemotherapy. I want to tell you how and why I came to write this book.
I started as a believer in chemotherapy. As a science writer at Memorial Sloan-Kettering Cancer Center in New York, I wrote articles praising the latest advances in chemotherapy. I was impressed by the then-emerging cures for Hodgkin's disease, acute lymphocytic leukemia and some other relatively rare cancers. At the same time, I began to learn how skeptical many good scientists were about chemotherapy's future.
The major objection to "chemo" was that these drugs did not discriminate between normal and cancerous cells, but attacked all rapidly dividing cells . One scientist described this method as "trying to melt a patient's left ear , while leaving the right one alone." It seemed particularly inappropriate in the treatment of solid tumors of adults, which are often slow-growing.
Because chemotherapy drugs were general cellular poisons, they could be terribly toxic. They were also very expensive for patients and for society as a whole. When I learned about the links between the pharmaceutical industry and the cancer establishment (later detailed in my book, The Cance r Industry) I understood the commercial reason that such an inadequate modality was so heavily promoted.
In 1989, a German biostatistician named Ulrich Abel, Ph.D. published a groundbreaking monograph called "Chemotherapy of Advanced Epithelial Cancer. It made few waves in the U.S. and soon went out of print. In this excellent work, however, Dr. Abel rigorously demonstrated that chemotherapy had never been scientifically proven to extend life through randomized clinical trials (RCTs) in the vast majority of "epithelial cancers." These are the common types of carcinoma that affect most cancer patients in the Western world.
Some years later, in response to many requests, I decided to write a critical book about chemotherapy (a sort of companion piece to Cancer Therapy). I took Abel's out-of-print work as my starting point, but also consulted the work of many other students of chemotherapy. In this book, I update statistics and speak about all cancers and not just carcinomas. I go into depth on the politics and economics of the chemotherapy industry, on the biases, fallacies and frauds that occur, and on ways of warding off the sometimes catastrophic side effects that accompany this treatment.
The essential point of the book is that one must question the measure of success in chemotherapy. Oncologists have tended to equate an increasing percentage of "responses" with progress. However, responses are generally measurements of tumor shrinkage, for as little as one month's duration. One cannot automatically assume that a response--even a complete response--will lead to increased survival. One must look for increased survival. Yet the number of cancers for which life prolongation through chemotherapy has been proven through randomized clinical trials is very small. (I do bend over backwards to point these out, when they occur.)
So when a doctor says her regimen yields a 40 percent response rate, "what exactly is she promising? A short-term shrinkage of tumors--or actual life-prolongation? What effect is this treatment likely to have on the patient's quality of life? And what is the cost?" It is only by obtaining information such as this that patients are able to make rational treatment choices. Questioning Chemotherapy is intended to help patients by providing them with a critical perspective on this now dominant modality.

Book Details Questioning Chemotherapy
  • Paperback: 214 pages
  • Publisher: Equinox Press (January 25, 1995)
  • Language: English
  • ISBN-10: 188102525X
  • ISBN-13: 9781881025252
  • Product Dimensions: 8.2 x 5.4 x 0.7 inches
  • List Price: $19.95
  • Price: $13.57
  • You Save: $6.38 (32%)
Buy Button

The Cancer Chemotherapy Handbook (6th Edition)

  • Title: The Cancer Chemotherapy Handbook (Sixth Edition)
  • Authors: David S. Fischer, Henry J. Durivage, M. Tish, Nancy Beaulieu
  • Paperback: 640 pages
  • Publisher: Mosby; 6 edition (May 16, 2003)
  • Language: English
  • ISBN-10: 0323018904
  • ISBN-13: 978-0323018906
  • Book Dimensions: 7.2 x 4.3 x 0.9 inches
  • List Price: $54.95
  • Amazon.com Price: $46.80
  • You Save: $8.15 (15%)
The Fischer handbook offers a more user-friendly, clearer presentation and an important chapter on the principles and applications of clinical trials. Here's a comprehensive, yet compact and practical guide to the care and chemotherapeutic treatment of cancer patients. It encompasses all major chemotherapeutic agents and combinations, investigational and newly approved drugs, and describes their mechanisms of action, indications, metabolism, dose, administration, toxicity, and drug interactions and incompatibilities. The 6th Edition includes more than 75 new drug regiments as well as a new chapter on medication errors and safety.

Racing to a Cure: A Cancer Victim Refuses Chemotherapy and Finds Tomorrow's Cures in Today's Scientific Laboratories

  • Title: Racing to a Cure: A Cancer Victim Refuses Chemotherapy and Finds Tomorrow's Cures in Today's Scientific Laboratories
  • Author: Neil Ruzic
  • List Price: $19.95
  • Paperback: 456 pages
  • Publisher: University of Illinois Press (March 7, 2006)
  • Language: English
  • ISBN-10: 0252073576
  • ISBN-13: 978-0252073571
  • Book Dimensions: 8.8 x 5.8 x 0.8 inches
Racing to a Cure is not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system, whose spread is reaching epidemic levels in the U.S. and Europe. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by investigating cures being developed in the nation's cancer-research laboratories.
Although chemotherapy harms the immune system and is increasingly demonstrated to be an ineffective long-term cure for the vast majority of cancers, it remains the standard treatment for most cancer patients. Ruzic, a former scientific magazine publisher and originator of a science center, refused to accept this status quo, and instead plunged into the world of cutting-edge treatments, exploring the frontiers of cancer science with revolutionary results.
Ruzic went on the offensive: visiting scores of laboratories, gathering information, talking to researchers, and effectively becoming his own patient-care advocate. This book presents his findings. A scathing critique of the chemotherapy culture as well as unscientific "alternative" therapies, the book endorses state-of-the-art molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians.
Neil Ruzic was expected to die within two years of his initial diagnosis. Five years later he has been declared cancer-free and considers himself cured.

Physicians' Cancer Chemotherapy Drug Manual 2006

Completely revised and updated for 2006, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalogue of over 100 drugs-both on- and off-label-commonly used in cancer treatment, including several new agents (recently or about to be FDA approved). A section on Common Chemotherapy Regimens provides a quick reference to management of specific cancers, arranged alphabetically. A comprehensively revised introductory chapter on Principles of Chemotherapy offers a concise, current overview of the field.
Special features include:
  • Special chapter profiling anti-emetic drugs.
  • Diagrams of drug structures and pathways.
  • Complete discussion of clinical pharmacology, indications, and dosages.
  • Coverage of toxicity and interactions.
  • Separate chapter on chemotherapy regimens for specific cancers.
  • Overview of basic principles of cancer drug therapy.
  • Easy to load and use CD-ROM version.
Book Info
Annual pocket-sized reference provides up-to-date information on all aspects of cancer chemotherapy. Discusses more than 100 commonly used drugs in cancer treatment. Profiles anti-emetic drugs, presents diagrams of drug structures and pathways, discusses clinical pharmacology, indications, and dosages, and more. Wire-spiral binding.

Book Details
  • Title: Physicians' Cancer Chemotherapy Drug Manual 2006
  • Editors: Edward, M.D. Chu, Vincent T. Devita
  • List Price: $73.95
  • Spiral-bound: 546 pages
  • Publisher: Jones & Bartlett Publishers; Bk&CD-Rom edition (January 3, 2006)
  • Language: English
  • ISBN-10: 0763740195
  • ISBN-13: 9780763740191
  • Book Dimensions: 8.5 x 5.5 x 1.2 inches
Update:
Physician's Cancer Chemotherapy Drug Manual 2008

57 Good Things About Chemotherapy

  • Title: 57 Good Things About Chemotherapy
  • Author: Alec Kalla
  • Illustrator: Andy Williamson
  • List Price: $14.99
  • Paperback: 70 pages
  • Publisher: Not Avail (February 2001)
  • Language: English
  • ISBN-10: 0970914903
  • ISBN-13: 978-0970914903
  • Book Dimensions: 8.3 x 5.3 x 0.5 inches
Mr. Kalla was diagnosed with Non Hodgkin's Lymphoma in 1997, underwent eight sessions of chemotherapy, and pronounced in remission. The next year, X-rays indicated that there was still insurance money to be had, and Mr. Kalla's remission certificate was revoked. Fortunately, a team of good doctors and nurses took him in for high-dose chemo- and radiation therapy, followed by a stem cell rescue-transplant. More than two years later, their skills have permitted Mr. Kalla to combine his talents with those of Andy Williamson, an artist, writer and cinema afficionado of the Rocky Mountains, to produce a book that truly lifts the sprits of cancer patients and survivors.
Rare humor that brings laughter to the halls of oncology, 57 Good Things About Chemotherapy provides precious relief from the stress and worry of cancer. Written by cancer survivor Alec Kalla and illustrated by Andy Williamson, this book makes cancer patients, survivors and caregivers smile, laugh and rid themselves of pentup emotional stress.
About the Author
Alec Kalla is the author of the continuing Hank Eston mysteries begun in 1993 with Velvet(with M.J. Sullivan), Foul Play Press. He is a member of Mystery Writers of America, profiled in Who's Who in America, and lives near Conifer, Colorado.

Copyright 2010 Cancer Reviews Center - All Rights Reserved.
Designed by Web2feel.com | Bloggerized by Lasantha - Premiumbloggertemplates.com | Affordable HTML Templates from Herotemplates.com.